Eupatorium lindleyanum DC Ameliorates Carbon Tetrachloride-Induced Hepatic Inflammation and Fibrotic Response in Mice
Open Access
- 20 August 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (8) , 1228
Abstract
Background/Objectives: Eupatorium lindleyanum DC (Eup), a traditional Chinese medicinal herb, is widely used for treating inflammation-mediated diseases, including pneumonia. However, its potential therapeutic effects on inflammation-driven liver fibrosis remain to be elucidated. This study aimed to investigate the effects of Eup on carbon tetrachloride (CCl4)-induced liver fibrosis and elucidate its underlying mechanisms. Methods: The chemical constituents of Eup were analyzed using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-LC/MS). A CCl4-induced liver fibrosis murine model and LX-2 cells were used in study. Serum biochemical assays, histological analysis, qRT-PCR, ELISA, and Western blot were used to assess Eup’s anti-inflammatory and anti-fibrotic properties. RNA sequencing (RNA-seq) was employed to identify potential mechanisms, with validation by Western blot. Results: 89 and 49 compounds were identified in Eup under positive and negative ion modes, respectively. In vivo, Eup treatment decreased collagen deposition and expression levels of fibrosis-related genes, including collagen I and α-smooth muscle actin. Additionally, Eup alleviated hepatic inflammation. In vitro, Eup inhibited FBS-induced hepatic stellate cell (HSCs) activation. Gene set enrichment analysis (GSEA) indicated that Eup significantly downregulated the platelet-derived growth factor (PDGF)/platelet-derived growth factor receptor-beta (PDGFR-β) signaling pathway, which was further validated in both CCl4-induced fibrotic livers and PDGF-BB-activated HSCs using western blot. Conclusions: Eup attenuated liver fibrosis by inhibiting inflammation and suppressing HSCs activation via downregulating PDGF/PDGFR-β signaling pathway.Keywords
Funding Information
- National Natural Science Foundation of China (82200634, 82200663, 82104520, 2022J01200)
- Natural Science Foundation of Fujian Province (82200634, 82200663, 82104520, 2022J01200)
This publication has 57 references indexed in Scilit:
- New opportunities and challenges of natural products research: When target identification meets single-cell multiomicsActa Pharmaceutica Sinica B, 2022
- PDGF-PDGFR network differentially regulates the fate, migration, proliferation, and cell cycle progression of myogenic cellsCellular Signalling, 2021
- Toll-Like Receptor 5 Signaling Ameliorates Liver Fibrosis by Inducing Interferon β–Modulated IL-1 Receptor Antagonist in MiceThe American Journal of Pathology, 2020
- Embelin can protect mice from thioacetamide-induced acute liver injuryBiomedicine & Pharmacotherapy, 2019
- A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver diseaseEBioMedicine, 2019
- F1012‐2 inhibits the growth of triple negative breast cancer through induction of cell cycle arrest, apoptosis, and autophagyPhytotherapy Research, 2018
- Hepatic stellate cells as key target in liver fibrosisAdvanced Drug Delivery Reviews, 2017
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in miceHepatology, 2013
- p38 MAP kinase mediates platelet‐derived growth factor‐stimulated migration of hepatic myofibroblastsJournal of Cellular Physiology, 2002
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995